Multiple Myeloma in Relapse Recruiting Phase 1 / 2 Trials for Pomalidomide (DB08910)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02004275Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple MyelomaTreatment